Literature DB >> 19000491

[Adiponectin: an emerging cardiovascular risk factor. The REFERENCE Study].

Vivencio Barrios1, Ricardo Gómez-Huelgas, Rosario Rodríguez, Pedro de Pablos-Velasco.   

Abstract

INTRODUCTION AND
OBJECTIVES: Emerging cardiovascular (CV) risk factors such as adiponectin, glycosilated hemoglobin, waist circumference and the high-sensitivity C-reactive protein (hsCRP) level can aid CV risk stratification. It has been shown that classic factors alone are not sufficient to explain CV risk fully. The adiponectin level has been linked to insulin resistance, dyslipidemia and coronary artery disease. This study investigated how the levels of adiponectin and other emerging risk factors are related to CV events in the Spanish population.
METHODS: This cross-sectional study involved 999 patients. They were divided into cases, who had experienced a first CV event in the 3 months prior to the study, and controls. Anthropometric and laboratory parameters recorded both after the event and 3 years before the study started were obtained.
RESULTS: Both a low adiponectin level and a high hsCRP level were associated with the occurrence of a CV event. In addition, obesity and a triglyceride level > or = 150 mg/dL, both observed 3 years before the study, were also associated with the occurrence of an event. There was an inverse relationship between the plasma adiponectin level and waist circumference. Multivariate analysis identified the following significant variables: hsCRP level, a family history of early CV disease and the high-density lipoprotein cholesterol (HDL-C) level 3 years earlier.
CONCLUSIONS: A low adiponectin level is associated with abdominal obesity. Emergent risk factors do not improve the predictive ability of the Systematic Coronary Risk Evaluation (SCORE) algorithm (which includes total cholesterol, HDL-C, blood pressure and smoking). Further studies evaluating their contribution are needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19000491

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  4 in total

Review 1.  C-reactive protein: clinical and epidemiological perspectives.

Authors:  Juan Salazar; María Sofía Martínez; Mervin Chávez; Alexandra Toledo; Roberto Añez; Yaquelín Torres; Vanessa Apruzzese; Carlos Silva; Joselyn Rojas; Valmore Bermúdez
Journal:  Cardiol Res Pract       Date:  2014-02-06       Impact factor: 1.866

2.  Association of hypoadiponectemia with smokeless/dipping tobacco use in young men.

Authors:  Sardar Ahmad; Mohsin Shah; Jawad Ahmed; Aslam Khan; Hamid Hussain; Mary McVey; Asif Ali
Journal:  BMC Public Health       Date:  2015-10-19       Impact factor: 3.295

3.  Association between dietary saturated fat with cardiovascular disease risk markers and body composition in healthy adults: findings from the cross-sectional BODYCON study.

Authors:  Ezgi Ozen; Rada Mihaylova; Michelle Weech; Sam Kinsella; Julie A Lovegrove; Kim G Jackson
Journal:  Nutr Metab (Lond)       Date:  2022-03-03       Impact factor: 4.169

4.  The Long-Term Effects of Organophosphates Poisoning as a Risk Factor of CVDs: A Nationwide Population-Based Cohort Study.

Authors:  Dong-Zong Hung; Hao-Jan Yang; Yu-Fen Li; Cheng-Li Lin; Shih-Yu Chang; Fung-Chang Sung; Sally C W Tai
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.